DOCSLIB.ORG

Innate Immunity Part I: the Immediate Response Deborah A

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Innate Immunity Part I: the Immediate Response Deborah A Innate Immunity Part I: The Immediate Response Deborah A. Lebman, Ph.D. OBJECTIVES 1. Describe three mechanisms present at epithelial surfaces that protect the host from pathogens. 2. List 3 functions of complement proteins in innate immunity 3. Know the primary functions of macrophages and neutrophils 4. List the receptors on macrophages involved in recognition of pathogens 5. List the key toxic products of phagocytes READING • Parham, The Immune System, pg 227-238. TERMS • Defensin: antibacterial peptide produced by the host at epithelial surfaces • Complement: ubiquitously present proteins synthesized primarily in the liver that mediate a variety of responses to pathogens • Opsonin (opsonization): alteration of cell surface that facilitates phagocytosis • Phagocytosis: internalization of particulate matter by cells • CD14: LPS receptor • TLR-4: toll like receptor 4 I. Introduction A. The first response to pathogens occurs immediately B. The early response employs both mechanical and cell mediated mechanisms C. There is no cellular expansion, but there is cell recruitment D. A wide array of soluble mediators with both positive and negative effects, i.e. remove the pathogen but hurt the host, is released II. Overview of Pathogens A. There are four types of pathogen: bacteria, virus, fungus, parasite B. Table I: Examples of the Four Types of Common Human Pathogen Table 1: Examples of the Four Types of Common Human Pathogen Table 1 (Continued): Examples of the Four Types of Common Human Pathogen C. Pathogens can be intracellular or extracellular Table 2: Examples of intracellular and extracellular pathogens. Notice that both innate and adaptive mechanisms are involved in the response to both types of pathogen. D. Pathogens enter the host at either mucosal surfaces (internal epithelium) or through the skin 1. Mucosal surfaces include the airway, gastrointestinal and reproductive tract 2. Entry via the external epithelium requires an injury such as a wound or insect bite 3. In order to succeed, the pathogen must form an initial focus or colony III. The First Defenses A. Epithelial Surfaces 1. Both external and internal epithelia are “active” barriers a. Tight junctions provide a mechanical barrier b. The flow of both air and mucus prevents bacterial adherence 2. Several anti-bacterial products are secreted at epithelial surfaces a. Enzymes: Lysozyme breaks bacterial cell walls b. Defensins: antibacterial peptides produced by underlying cells 3. Normal flora defends against pathogenic flora a. Flora can be both active and passive b. “passive” –occupies space preventing pathogens from gaining a foothold c. “active”—secrete anti-microbial substances, e.g., colicins d. Clinical note: a common problem following treatment with antibiotics is candidiasis. When the antibiotic kills normal flora along with pathogenic organism, it becomes possible for yeast to colonize epithelium. Table 3: The three levels of protection provided by epithelial barriers. B. Complement 1. Complement consists of over 30 plasma proteins. >90% are produced in the liver. Some of the proteins are produced by moncytes/macrophages and fibroblasts 2. Complement proteins are always present and ready which means that as soon as the exterior boundaries are breached, complement comes into play. 3. There are multiple pathways for activation of complement (another lecture) 4. The pathway of complement activation at this early time point in an infection is the alternative pathway. 5. Key steps in the alternative pathway of activation 6. C3 undergoes spontaneous hydrolysis (this occurs all the time) a. Hydrolyzed C3 interacts with factor B and is cleaved to C3b and C3a b. C3b “dies” unless it binds to a cell c. On the cell surface, C3b interacts with factor B which is cleaved to Bb by factor D d. Stabilized C3bBb is an active complex that “converts” or cleaves C3 into C3b and allows C3b to coat the cell surface i. On bacterial surfaces properdin stabilizes C3bBb e. C3b is the functional moiety: i. It is a ligand for a macrophage receptor so it promotes phagocytosis (C3b is an opsonin) ii. It also promotes formation of a complex of complement proteins (membrane attack complex) that punches holes in cell surfaces Figure 1: Steps in the formation of the active complex C3bBb iii. Host cells are spared because C3bBb is not formed or stabilized on the host cell surface iv. Host cells express several proteins (CR1, DAF, MCP, Factor H) that disrupts C3bBb Figure 2: Complement is activated on pathogen, but not host cells because host cells make proteins that prevent formation of C3bBb on the surface and deposition of C3b. v. A third function of complement is to promote inflammation vi. C3b production also leads to the activation of other components of complement, most notably C5a,C3a, and C4a, which act on blood vessels to increase permeability ultimately leading to cellular influx and inflammation Figure 3: Complement components promote vascular leakage and inflammatory response. IV. The Immune Cell Mediated Early Innate Response A. Effector Cells 1. Macrophages/Monocytes a. Macrophages which are derived from blood monocytes reside in tissue. They tend to be localized to connective tissue, the aerodigestive tract, the genitourinary tract and the liver. Liver macrophages are Kupfer cells. Macrophages are long lived. b. Macrophages have three primary functions: phagocytosis, secrection of enzymes (very important, this leads to the induced innate immune response), and antigen presentation. They are a key player in both innate and adaptive immunity. 2. Neutrophils a.k.a. Polymorphonuclear leukoctyes (PMN) a. Smaller than macrophages b. Granulocytes c. Most abundant white blood cell d. Not present in healthy tissue e. Short-lived f. Primary functions of PMNs are phagocytosis and cytokine production 3. NK cells a.k.a. Large Granular Lymphocytes a. Major role is in viral infection b. Primary functions of NK cells are killing of virally infected cells and cytokine production 4. Miscellaneous cell types a. There are two types of cell that are believed to interface the innate and adaptive immune responses: T cells and B-1 B cells B. Recognition of Pathogens 1. Danger vs Stranger a. Innate immune cells have to distinguish self from non-self as well as non- pathogenic from pathogenic micro-organisms b. Two hypotheses as to how “recognition” is accomplished. i. The Danger Hypothesis: pathogens alert the host by causing tissue damage, i.e, a Danger Signal ii. The Stranger Hypothesis: pathogens have molecular patterns that are recognized by receptors on host immune cells 2. Danger Signals a. Until recently, there was very little convincing evidence for the existence of danger signals. There were a couple of intriguing possibilities such as heat shock proteins. b. Last Fall (October 2003), Shi, et al reported in Nature the existence of a “true” danger signal. Invading micro-organisms stimulate epithelial cells to release uric acid crystals which activate dendritic cells (potent antigen presenting cells). c. Clinical note: Gout, an acute form of arthritis associated with inflammation, is caused by uric acid crystals in joints. However, the relevance of this association is at the moment unclear. 3. Stranger Signals and The Receptors on Immune Cells a. Macrophages and neutrophils have receptors for components of complement (CR3, CR4) i. Complement coating of pathogens targets them for opsonization via these receptors b. Pattern Recognition Molecules i. Microbe surfaces have repeating structural patterns or PAMP (pathogen associated molecular patterns) ii. Immune cells have receptors for PAMPs • Mannose receptor, glycan receptor, and scavenger receptor recognize carbohydrates • CD14 or the LPS receptor recognizes lipopolysaccharide which is a component of the cell walll of gram negative bacteria, e.g., E. coli Figure 4: Receptors on phagocytes lead to recognition and engulfment of bacteria. 4. Toll Receptors a. Toll receptors are a family of proteins (10 to date) that contribute to signal transduction induced by the interaction of PAMPs with their receptors. They do not recognize PAMPs. b. May respond to damage signals induced by inflammation c. Clinical note: Toll receptors or mutations in toll receptors appear to play a role in inflammatory diseases including Crohn’s disease and atherosclerosis. This is a very young field, but therapeutic interventions that involve manipulations of these receptors are on the horizon. d. TLR-4 i. Responsible for signal transduction following binding to CD14 ii. Signaling results in induction of expression of surface proteins that enhance adaptive immunity and cytokine production Figure 5: Following ligation of CD14 with bacterial LPS, TLR-4 induces cell signaling resulting in initiation of transcription of genes for both cell surface proteins and cytokines. A key transcription factor in this process is NF- B C. The initial cellular response: Phagocytosis 1. Recognition leads to engulfment of phagocytosis by macrophages and neutrophils 2. Endocytosed or phagocytosed microbe forms a membrane bound vesicle called a phagosome 3. Phagosome fuses with a lysozome to form a phagolysozome. The pH drops which can kill the micro-organism. 4. Phagocytes (macrophages and neutrophils) produce a variety of toxic products a. The respiratory burst i. Lysozomes have NADPH oxidases which generate toxic oxygen species including hydrogen peroxide, superoxide anions and nitric oxide. This early response is called the respiratory burst. ii. Clinical note: There are individuals who have defects in NADPH oxidase. They are susceptible to bacterial infections b. Antimicrobial peptides i. Defensins, cationic proteins c. Enzymes i. Myeloperoxidase: generates toxic oxygen derivatives ii. Lysozyme: dissolves gram negative cell walls iii. Acid hydrolases: digest bacteria d. Competitors i. Substances that compete with the bacteria for nutrients, e.g., lactoferrin which binds iron and Vitamin B12 binding protein .
Load more

Recommended publications
  • Human Illness Caused by E. Coli O157:H7 from Food and Non-Food Sources
    FRI BRIEFINGS Human Illness Caused by E. coli O157:H7 from Food and Non-food Sources M. Ellin Doyle1*, John Archer2, Charles W. Kaspar1, and Ronald Weiss1 1Food Research Institute, University of Wisconsin–Madison, Madison, WI 53706 2Wisconsin Division of Public Health, Bureau of Communicable Diseases and Preparedness, Communicable Disease Epidemiology Section, Madison, WI 53702 Contents Introduction ...................................................................................................................................2 Epidemiology of E. coli O157:H7..................................................................................................2 Outbreak Data ........................................................................................................................2 Reservoirs of E. coli O157:H7 ..............................................................................................3 Cattle—the primary reservoir ........................................................................................3 Other ruminants .............................................................................................................4 Other animals .................................................................................................................4 Transport Hosts......................................................................................................................4 Routes of Human Infection ....................................................................................................5
    [Show full text]
  • How Do Pathogenic Microorganisms Develop Cross-Kingdom Host Jumps? Peter Van Baarlen1, Alex Van Belkum2, Richard C
    Molecular mechanisms of pathogenicity: how do pathogenic microorganisms develop cross-kingdom host jumps? Peter van Baarlen1, Alex van Belkum2, Richard C. Summerbell3, Pedro W. Crous3 & Bart P.H.J. Thomma1 1Laboratory of Phytopathology, Wageningen University, Wageningen, The Netherlands; 2Department of Medical Microbiology and Infectious Diseases, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands; and 3CBS Fungal Biodiversity Centre, Utrecht, The Netherlands Correspondence: Bart P.H.J. Thomma, Abstract Downloaded from https://academic.oup.com/femsre/article/31/3/239/2367343 by guest on 27 September 2021 Laboratory of Phytopathology, Wageningen University, Binnenhaven 5, 6709 PD It is common knowledge that pathogenic viruses can change hosts, with avian Wageningen, The Netherlands. Tel.: 10031 influenza, the HIV, and the causal agent of variant Creutzfeldt–Jacob encephalitis 317 484536; fax: 10031 317 483412; as well-known examples. Less well known, however, is that host jumps also occur e-mail: [email protected] with more complex pathogenic microorganisms such as bacteria and fungi. In extreme cases, these host jumps even cross kingdom of life barriers. A number of Received 3 July 2006; revised 22 December requirements need to be met to enable a microorganism to cross such kingdom 2006; accepted 23 December 2006. barriers. Potential cross-kingdom pathogenic microorganisms must be able to First published online 26 February 2007. come into close and frequent contact with potential hosts, and must be able to overcome or evade host defences. Reproduction on, in, or near the new host will DOI:10.1111/j.1574-6976.2007.00065.x ensure the transmission or release of successful genotypes.
    [Show full text]
  • Differences in Innate Immune Response Between Man and Mouse
    Institute of Medical Physics and Biophysics Medical Department, Leipzig University Author Manuscript © 2014. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ Published in final edited form as: Critical Reviews™ in Immunology, 2014; 34:433-54. Available at: http://dx.doi.org/ 10.1615/CritRevImmunol.2014011600. DIFFERENCES IN INNATE IMMUNE RESPONSE BETWEEN MAN AND MOUSE Josefin Zschaler 1,2,*, Denise Schlorke 1,2,* & Juergen Arnhold 1,2 1 Institute for Medical Physics and Biophysics, Medical Faculty, Leipzig University, Leipzig, Germany 2 Translational Centre for Regenerative Medicine (TRM), Leipzig University, Leipzig, Germany * Both authors contributed equally to this work. Abstract Mouse strains are frequently used to model human disease states, to test the efficiency of drugs and therapeutic principles. However, the direct translation of murine experimental data to human pathological events often fails due to sufficient differences in the organization of the immune system of both species. Here we give a short overview of the principle differences between mice and humans in defense strategies against pathogens and mechanisms involved in response to pathogenic microorganisms and other activators of the immune system. While in human blood mechanisms of immune resistance are highly prevailed, tolerance mechanisms dominate for the defense against pathogenic microorganisms in mouse blood. Further on, species-related differences of immune cells mainly involved in innate immune response as well as differences to maintain oxidative homeostasis are also considered. A number of disease scenarios in mice are critically reflected for their suitability to serve as a model for human pathologies.
    [Show full text]
  • The Public Health Impact of Prion Diseases1
    10 Feb 2005 13:10 AR AR238-PU26-08.tex AR238-PU26-08.sgm LaTeX2e(2002/01/18) P1: IBD 10.1146/annurev.publhealth.26.021304.144536 Annu. Rev. Public Health 2005. 26:191–212 doi: 10.1146/annurev.publhealth.26.021304.144536 Copyright ©c 2005 by Annual Reviews. All rights reserved First published online as a Review in Advance on December 8, 2004 THE PUBLIC HEALTH IMPACT OF PRION DISEASES1 Ermias D. Belay and Lawrence B. Schonberger Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333; email: [email protected] KeyWords transmissible spongiform encephalopathy, Creutzfeldt-Jakob disease, variant Creutzfeldt-Jakob disease, bovine spongiform encephalopathy, chronic wasting disease ■ Abstract Several prion disease–related human health risks from an exogenous source can be identified in the United States, including the iatrogenic transmission of Creutzfeldt-Jakob disease (CJD), the possible occurrence of variant CJD (vCJD), and potential zoonotic transmission of chronic wasting disease (CWD). Although cross- species transmission of prion diseases seems to be limited by an apparent “species barrier,” the occurrence of bovine spongiform encephalopathy (BSE) and its transmis- sion to humans indicate that animal prion diseases can pose a significant public health risk. Recent reports of secondary person-to-person spread of vCJD via blood products and detection of vCJD transmission in a patient heterozygous at codon 129 further illustrate the potential public health impacts of BSE. INTRODUCTION by IRMO/Information Center on 03/14/05. For personal use only. Prion diseases, also known as transmissible spongiform encephalopathies (TSEs), are a group of animal and human brain diseases that are uniformly fatal and often characterized by a long incubation period and a multifocal neuropathologic picture of neuronal loss, spongiform changes, and astrogliosis (3).
    [Show full text]
  • Supporting Information
    Supporting Information Rosenberg et al. 10.1073/pnas.1307243110 SI Results and Discussion domestic ungulates (horses, cows, sheep, goats, camels, and pigs) Of the 83 arboviruses, nonhuman vertebrate hosts have been and rodents in both groups might be a consequence of spatial identified for 70 (84%); the remaining 13 are presumed to be proximity to humans. Sentinel monkeys were often used in pro- zoonoses because there is no indication they can be transmitted cedures to isolate arboviruses, which might account for their directly between humans by vectors (Table S1). Animal hosts have higher representation among arboviruses. In contrast, there are been identified for at least 57 (44%) of the 130 nonarboviruses; an few published records of bats being routinely sampled during additional 5 (8%) are presumed on epidemiological evidence to arbovirus studies, and only two arboviruses (3%) have been iso- have nonhuman reservoirs (Table S1). A number of viruses infect lated from bats. The reason a much larger number of arbovirus more than one nonhuman vertebrate host species and it is likely species (n = 16) have been isolated from birds than have that the variety of hosts is wider than has been recorded. The nonarbovirus species (n = 1) might, however, be characteristic of predominant host groups for arboviruses (n = 70) are nonhuman the pathogenicity of the togaviruses and flaviviruses, which are primates (31%), rodents (29%), ungulates (26%), and birds (23%); much more common among the arboviruses. The most prominent for the nonarboviruses (n = 57), they are rodents (30%), ungu- vectors of arboviruses were mosquitoes (67%), ticks (19%), and lates (26%), bats (23%), and primates (16%).
    [Show full text]
  • Spillback in the Anthropocene: the Risk of Human-To-Wildlife Pathogen Transmission for Conservation and Public Health
    Spillback in the Anthropocene: the risk of human-to-wildlife pathogen transmission for conservation and public health Anna C. Fagre*1, Lily E. Cohen2, Evan A. Eskew3, Max Farrell4, Emma Glennon5, Maxwell B. Joseph6, Hannah K. Frank7, Sadie Ryan8, 9,10, Colin J Carlson11,12, Gregory F Albery*13 *Corresponding authors: [email protected]; [email protected] 1: Department of Microbiology, Immunology, and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 2: Icahn School of Medicine at Mount Sinai, New York, NY 10029 3: Department of Biology, Pacific Lutheran University, Tacoma, WA, 98447 USA 4: Department of Ecology & Evolutionary Biology, University of Toronto 5: Disease Dynamics Unit, Department of Veterinary Medicine, University of Cambridge, Cambridge CB3 0ES, UK 6: Earth Lab, University of Colorado Boulder, Boulder, CO 80309 7: Department of Ecology and Evolutionary Biology, Tulane University, New Orleans, LA, 70118 USA 8: Quantitative Disease Ecology and Conservation (QDEC) Lab Group, Department of Geography, University of Florida, Gainesville, FL, 32610 USA 9: Emerging Pathogens Institute, University of Florida, Gainesville, FL, 32610 USA 10: School of Life Sciences, University of KwaZulu-Natal, Durban, 4041, South Africa 11: Center for Global Health Science and Security, Georgetown University Medical Center, Washington, DC, 20057 USA 12: Department of Microbiology and Immunology, Georgetown University Medical Center, Washington, DC, 20057 USA 13: Department of Biology, Georgetown University, Washington, DC, 20057 USA 1 Abstract The SARS-CoV-2 pandemic has led to increased concern over transmission of pathogens from humans to animals (“spillback”) and its potential to threaten conservation and public health.
    [Show full text]
  • Risk of Human Pathogen Internalization in Leafy Vegetables During Lab-Scale Hydroponic Cultivation
    horticulturae Review Risk of Human Pathogen Internalization in Leafy Vegetables During Lab-Scale Hydroponic Cultivation Gina M. Riggio 1, Sarah L. Jones 2 and Kristen E. Gibson 2,* 1 Cellular and Molecular Biology Program, Department of Food Science, University of Arkansas, Fayetteville, AR 72701, USA; [email protected] 2 Department of Food Science, University of Arkansas, Fayetteville, AR 72704, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-479-575-6844 Received: 13 February 2019; Accepted: 7 March 2019; Published: 15 March 2019 Abstract: Controlled environment agriculture (CEA) is a growing industry for the production of leafy vegetables and fresh produce in general. Moreover, CEA is a potentially desirable alternative production system, as well as a risk management solution for the food safety challenges within the fresh produce industry. Here, we will focus on hydroponic leafy vegetable production (including lettuce, spinach, microgreens, and herbs), which can be categorized into six types: (1) nutrient film technique (NFT), (2) deep water raft culture (DWC), (3) flood and drain, (4) continuous drip systems, (5) the wick method, and (6) aeroponics. The first five are the most commonly used in the production of leafy vegetables. Each of these systems may confer different risks and advantages in the production of leafy vegetables. This review aims to (i) address the differences in current hydroponic system designs with respect to human pathogen internalization risk, and (ii) identify the preventive control points for reducing risks related to pathogen contamination in leafy greens and related fresh produce products. Keywords: hydroponic; leafy greens; internalization; pathogens; norovirus; Escherichia coli; Salmonella; Listeria spp.; preventive controls 1.
    [Show full text]
  • Genomics-Based Re-Examination of the Taxonomy and Phylogeny Of
    University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Food and Drug Administration Papers U.S. Department of Health and Human Services 2020 Genomics-based re-examination of the taxonomy and phylogeny of human and simian Mastadenoviruses: an evolving whole genomes approach, revealing putative zoonosis, anthroponosis, and amphizoonosis June Kang George Mason University Ashrafali Mohamed Ismail Harvard Medical School Shoaleh Dehghan George Mason University Jaya Rajaiya Harvard Medical School FMarollowc W this. Allar andd additional works at: https://digitalcommons.unl.edu/usfda US Food & Drug Administration Part of the Dietetics and Clinical Nutrition Commons, Health and Medical Administration Commons, Health Services Administration Commons, Pharmaceutical Preparations Commons, and the Pharmacy AdministrSee next pageation, for Policy additional and Regulation authors Commons Kang, June; Ismail, Ashrafali Mohamed; Dehghan, Shoaleh; Rajaiya, Jaya; Allard, Marc W.; Lim, Haw Chuan; Dyer, David W.; Chodosh, James; and Seto, Donald, "Genomics-based re-examination of the taxonomy and phylogeny of human and simian Mastadenoviruses: an evolving whole genomes approach, revealing putative zoonosis, anthroponosis, and amphizoonosis" (2020). Food and Drug Administration Papers. 47. https://digitalcommons.unl.edu/usfda/47 This Article is brought to you for free and open access by the U.S. Department of Health and Human Services at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Food and
    [Show full text]
  • Laboratory Activities to Enhance the Study of Whole Blood Components and Their Role in the Immune Response
    Laboratory Activities to Enhance the Study of Whole Blood Components and their Role in the Immune Response Thomas E. Schmit John H. Wallace Teacher Fellow Hamilton High School 327 Fairgrounds Road Hamilton, MT 59840 [email protected] Table Of Contents Teacher Guide Overview...................................................................................................................1 Science Background..................................................................................................1 Student Outcomes......................................................................................................4 Learning Objectives....................................................................................................4 Time Requirements.....................................................................................................4 Advance Preparation...................................................................................................4 Materials and Equipment............................................................................................4 Student Prior Knowledge............................................................................................6 What Is Expected From the Students..........................................................................7 Anticipated Results.....................................................................................................7 Classroom Discussion.................................................................................................8
    [Show full text]
  • Ecology of Pathogenic E.Coli - Stefano Morabito
    MEDICAL SCIENCES - Ecology Of Pathogenic E.Coli - Stefano Morabito ECOLOGY OF PATHOGENIC E. coli Stefano Morabito European Reference Laboratory for Escherichia coli including VTEC. Foodborne zoonoses Unit; Department of Veterinary Public Health and Food Safety Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome. Italy. Keywords: Escherichia coli, pathogenicity, genomic plasticity, survival, environment, colonization, animal reservoirs, zoonosis. Contents 1. Introduction 2. Pathogenic E. coli types 3. Ecology of Pathogenic E. coli Circulating in Humans 4. The Zoonotic Connection 5. Ecology of Zoonotic E. coli 6. Pathogenic Escherichia coli Producing Biofilm 7. Signaling In the Gastro-Intestinal Tract and Pathogenesis 8. E. coli Pathotypes with Atypical Combination of Virulence Factors 9. Acknowledgments Glossary Bibliography Biographical Sketch Summary Escherichia coli is a ubiquitous bacterial species. It is part of the intestinal microflora of humans and warm-blooded animals and, at the same time, is among the most diffuse bacterial species in the environment. The pivotal aspect of this success is represented by an exceptional genomic plasticity. As a matter of fact, E. coli is capable to exchange genetic material with other bacteria, often belonging to different species, through horizontal gene transfer, a process involving the action of mobile genetic elements, such as bacteriophages, transposons, pathogenicity islands and plasmids. The relationships between E. coli and the human host are generally based on commensalism and yet this species exerts a beneficial effect in the gut, however, some strains evolved the capability to harm and cause disease either involving the gastro- intestinal tract or in other organism‘s districts. Most of the pathogenic E.
    [Show full text]
  • Genomic Characterization of Human Adenovirus Type 4 Strains Isolated
    Virology 538 (2019) 11–23 Contents lists available at ScienceDirect Virology journal homepage: www.elsevier.com/locate/virology Genomic characterization of human adenovirus type 4 strains isolated T worldwide since 1953 identifies two separable phylogroups evolving at different rates from their most recent common ancestor ∗ Gabriel Gonzaleza, ,1, Camden R. Bairb,1, Daryl M. Lamsonc, Hidemi Watanabed, Laura Pantod, ∗∗ Michael J. Carre,f, Adriana E. Kajonb, a Research Center for Zoonosis Control, Hokkaido University, Sapporo, Japan b Infectious Disease Program, Lovelace Respiratory Research Institute, New Mexico, USA c Wadsworth Center, New York State Department of Health, New York, USA d Graduate School of Information Science and Technology, Hokkaido University, Japan e Global Institution for Collaborative Research and Education (GI-CoRE), Hokkaido University, Japan f National Virus Reference Laboratory, School of Medicine, University College Dublin, Ireland ARTICLE INFO ABSTRACT Keywords: Species Human mastadenovirus E (HAdV-E) comprises several simian types and a single human type: HAdV-E4, a Adenovirus type 4 respiratory and ocular pathogen. RFLP analysis for the characterization of intratypic genetic variability has Human mastadenovirus E previously distinguished two HAdV-E4 clusters: prototype (p)-like and a-like. Our analysis of whole genome Genetic diversity sequences confirmed two distinct lineages, which we refer to as phylogroups (PGs). PGs I and II comprisethep- Evolution and a-like genomes, respectively, and differ significantly in their G + C content (57.7% ±0.013vs 56.3% ± 0.015). Sequence differences distinguishing the two clades map to several regions of the genome including E3 and ITR. Bayesian analyses showed that the two phylogroups diverged approximately 602 years before the present.
    [Show full text]
  • The Characteristics of Pandemic Pathogens
    Center for Health Security The Characteristics of PANDEMIC PATHOGENS Improving Pandemic Preparedness by Identifying the Attributes of Microorganisms Most Likely to Cause a Global Catastrophic Biological Event Center for Health Security The Characteristics of PANDEMIC PATHOGENS PROJECT TEAM Amesh A. Adalja, MD, Project Director Matthew Watson, BS Eric S. Toner, MD Anita Cicero, JD Thomas V. Inglesby, MD Copyright © 2018 by Johns Hopkins University EXECUTIVE SUMMARY The Characteristics of PANDEMIC PATHOGENS Background and Purpose of Report CONTENTS he Johns Hopkins Center for Health Security conducted this study to elucidate the characteristics T of naturally occurring microorganisms that constitute a global catastrophic biological risk (GCBR). 3 Executive Summary GCBRs are defined as “those events in which biological agents—whether naturally emerging or 8 Introduction 9 Purpose, Methods, and Analysis reemerging, deliberately created and released, or laboratory engineered and escaped—could lead to 10 Basis of Recommendations sudden, extraordinary, widespread disaster beyond the collective capability of national and international 18 Recommendations governments and the private sector to control. If unchecked, GCBRs would lead to great suffering, loss of 22 Future Directions life, and sustained damage to national governments, international relationships, economies, societal 22 Conclusion 23 References stability, or global security.” 26 Appendix A: List of Experts Interviewed 28 Appendix B: Meeting Participants The overarching aim of the study was to provide an inductive, microbe-agnostic analysis of the microbial world to identify fundamental principles that underlie this special category of microorganisms that have potential to cause global catastrophe. Such principles could refine pandemic preparedness by providing a new framework or lens through which to survey the threat landscape of infectious diseases in order to better anticipate, prepare for, and respond to GCBR threats.
    [Show full text]